5-(甲氧羰基)-2-吡啶羧酸 | 17874-79-2

• 物质功能分类: 医药中间体 - 杂环化合物 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 5-(甲氧羰基)-2-吡啶羧酸
• 中文别名: 5-甲氧羰基-2-吡啶甲酸；5-甲氧基羰酰吡啶-2-羧酸；5-(甲氧羰基)吡啶-2-羧酸；5-(甲氧羰基)-2-吡啶甲酸
• 英文名称: pyridine-2,5-dicarboxylic acid 5-methyl ester
• 英文别名: 5-(methoxycarbonyl)picolinic acid；5-(methoxycarbonyl)pyridine-2-carboxylic acid；5-(methoxycarbonyl)-2-pyridinecarboxylic acid；5-methoxycarbonylpyridine-2-carboxylic acid
• CAS: 17874-79-2
• 化学式: C₈H₇NO₄
• mdl: MFCD00179343
• 分子量: 181.148
• InChiKey: NTCKZTBRFXTYBD-UHFFFAOYSA-N

物化性质

• 熔点：
  187 °C
• 沸点：
  347.9±27.0 °C(Predicted)
• 密度：
  1.361±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于氯仿（少量加热）、DMSO（少量）、甲醇（少量）

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  76.5
• 氢给体数：
  1
• 氢受体数：
  5

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xn
• 安全说明：
  S22,S26,S36/37/39
• 危险类别码：
  R22,R36/37/38
• 海关编码：
  2933399090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  室温和惰性气体环境下

SDS

Name:	5-(Methoxycarbonyl)pyridine-2-carboxylic acid 95+% Material Safety Data Sheet
Synonym:
CAS:	17874-79-2

Section 1 - Chemical Product MSDS Name:5-(Methoxycarbonyl)pyridine-2-carboxylic acid 95+% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
17874-79-2	5-(Methoxycarbonyl)pyridine-2-carboxyl	95+%	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 17874-79-2: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: slight pink
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 187 - 189 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H7NO4
Molecular Weight: 181

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, reducing agents, bases, amines.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 17874-79-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
5-(Methoxycarbonyl)pyridine-2-carboxylic acid - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 17874-79-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 17874-79-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 17874-79-2 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-(甲氧羰基)-2-吡啶羧酸 在 甲醇 作用下， 反应 48.0h， 以62%的产率得到烟酸甲酯
  参考文献：
  名称：

  不含金属的多相半导体用于羧酸的可见光光催化脱羧

  摘要：

  用不含金属的陶瓷氮化硼碳（BCN）开发了一种适合的光催化脱羧羧酸的方法。在可见光照射下，BCN将羧酸氧化成以碳为中心的自由基，这些自由基被氢原子供体俘获或用于构建碳-碳键。在该系统中，（杂）芳族和脂肪族酸均能顺利进行脱羧反应，并以中等至高收率形成C–H，C–D和C–C键（35个实例，最高收率93％）。对照实验支持自由基过程，同位素实验表明甲醇被用作氢原子供体。循环测试和克级反应阐明了异质陶瓷BCN光氧化还原系统的实用性。它为有价值的碳自由基中间体的形成提供了均相催化剂的替代方法。此外，不含金属的系统还适用于消炎药（如萘普生和布洛芬）的后期功能化，这些功能丰富了化学工具箱。

  DOI：

  10.1021/acscatal.0c05211
• 作为产物：
  描述：

  2,5-二吡啶羧酸 在 甲醇 、 sodium hydroxide 、 硫酸 作用下， 反应 21.0h， 生成 5-(甲氧羰基)-2-吡啶羧酸
  参考文献：
  名称：

  CONJUGATES OF ARTEMISININ-RELATED ENDOPEROXIDES AND HYDRAZONE DERIVATIVES FOR THE TREATMENT OF CANCER

  摘要：

  具有与联接剂通过连接剂共价耦合的肟基的青蒿素相关内过氧化物基团的化合物。使用这些化合物治疗癌症的组合物和方法。

  公开号：

  US20080103192A1
• 作为试剂：
  描述：

  (3-Fluoropyridin-2-yl)-[3-fluoro-4-(trifluoromethoxy)phenyl]methanamine;hydrochloride 、 5-(甲氧羰基)-2-吡啶羧酸 在 5-(甲氧羰基)-2-吡啶羧酸 作用下， 生成 (S)-methyl 6-(((3-fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoyl)nicotinate
  参考文献：
  名称：

  TRPM8 antagonists and their use in treatments

  摘要：

  公式I的化合物是TRPM8受体拮抗剂，对于治疗多种TRPM8介导的疾病和症状有用，并可用于制备治疗这些疾病和症状的药物和制剂。这些疾病的例子包括但不限于偏头痛和神经病性疼痛。公式I的化合物具有以下结构：其中变量的定义在此提供。

  公开号：

  US09096527B2

文献信息

• [EN] NOVEL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2015180612A1

  公开（公告）日：2015-12-03

  Disclosed are novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.

  揭示了新型视黄醇相关孤儿受体γ（RORγ）调节剂及其在通过RORγ介导的疾病治疗中的应用。
• Rhodium(III)-Catalyzed Oxidative Olefination of Picolinamides: Convenient Synthesis of 3-Alkenylpicolinamides
  作者：Jun Zhou、Bo Li、Zhen-Chao Qian、Bing-Feng Shi

  DOI：10.1002/adsc.201300895

  日期：2014.3.24

  A rhodium(III)‐catalyzed selective olefination of picolinamide derivatives has been developed. The reaction shows high regioselectivity, low catalyst loading (0.5 mol%), high yield and good functional group tolerance, providing a convenient strategy for the synthesis of 3‐alkenylpicolinamides.

  已开发了铑（III）催化的吡啶甲酰胺衍生物的选择性烯烃化反应。该反应显示出高区域选择性，低催化剂负载量（0.5 mol％），高收率和良好的官能团耐受性，为合成3-链烯基吡啶甲酸酰胺提供了便利的策略。
• Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
  申请人：Hormann Eugene Robert

  公开号：US20060020146A1

  公开（公告）日：2006-01-26

  The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.

  本发明涉及用于核受体基于诱导基因表达系统的非甾体配体，以及一种调节外源基因表达的方法，其中包括一个包含：DNA结合结构域；配体结合结构域；转活化结构域；和配体的ecdysone受体复合物与包含外源基因和响应元件的DNA构建物接触；其中外源基因受响应元件控制，并且在配体存在的情况下DNA结合结构域与响应元件结合导致基因的激活或抑制。
• Monofluoroalkyl derivatives
  申请人：Eli Lilly and Company

  公开号：US07034045B1

  公开（公告）日：2006-04-25

  The present invention provides certain monofluoroalkyl derivatives useful for potentiating glutamate receptor function in a mammal and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders.

  本发明提供了一些单氟代烷基衍生物，这些衍生物可用于增强哺乳动物中的谷氨酸受体功能，因此可用于治疗各种疾病，如精神和神经障碍。
• [EN] IMIDAZO[4,5-C]PYRIDINE AND PYRROLO[2,3-C]PYRIDINE DERIVATIVES AS SSAO INHIBITORS<br/>[FR] DÉRIVÉS D'IMIDAZO[4,5-C]PYRIDINE ET DE PYRROLO[2,3-C]PYRIDINE EN TANT QU'INHIBITEURS SSAO
  申请人：PROXIMAGEN LTD

  公开号：WO2014140592A1

  公开（公告）日：2014-09-18

  The compounds of formula (I) are inhibitors of semicarbazide- sensitive amine oxidase (SSAO) activity useful in the treatment of inflammation, an inflammatory disease, an immune or an autoimmune disorder, or inhibition of tumour growth.

  式(I)的化合物是半羧肼敏感胺氧化酶（SSAO）活性的抑制剂，可用于治疗炎症、炎症性疾病、免疫或自身免疫性疾病，或抑制肿瘤生长。

表征谱图